-
Biogen (BIIB) Q1 2024 Earnings Call Transcript
24 Apr 2024 17:04 GMT
BIIB earnings call for the period ending March 31, 2024.
Image source: The Motley Fool.
Biogen (BIIB 5.08%)
Q1 2024 Earnings Call
Apr 24, 2024, 8:30 a.m. ET
Contents: Prepared Remarks Questions and Answers Call Participants Prepared Remarks:
Operator
Good …
-
Exploring Innovations and Growth Drivers in the Huntington's Disease Treatment Market
05 Apr 2024 09:39 GMT
Surge in demand for advanced drug types for controlling symptoms associated with Huntington's drive growth of the Global Huntington's disease treatment market.
WILMINGTON, DELAWARE , UNITED STATES, April 5, 2024 /EINPresswire.com/ -- …
-
Huntington's Disease Market Report 2032: Epidemiology Data, Therapies, Latest FDA, EMA, PDMA Approvals by DelveInsight
25 Mar 2024 10:30 GMT
In the year 2021, the total prevalent cases of Huntington’s disease were ~80,200 in the 7MM which are expected to grow during the study period, i.e., 2019–2032.
LAS VEGAS, NEVADA, UNITED STATES, March 25, 2024 /EINPresswire.com/ -- DelveInsight’ …
-
Clinicians Slam FDA Over Approval of Opioid Addiction Test
05 Apr 2024 17:48 GMT
A group of researchers urged US regulators to revoke the approval of a test marketed for predicting risk for opioid addiction and said government health plans should not pay for the product.
The focus of the request is AdvertD (SOLVD Health), which the US …
-
New treatments in sight for challenging neuropsychiatric symptoms in neurodegenerative diseases
04 Apr 2024 02:58 GMT
In a recent study published in the journal JAMA Neurology, researchers reviewed the progress thus far in pharmacologically managing the various neuropsychiatric syndromes that manifest in neurodegenerative disorders and discussed the recent advances in …
-
Beyond plaques: New Alzheimer's treatment pathway discovered
27 Mar 2024 16:01 GMT
Researchers have discovered that limiting a certain enzyme can have a dramatic impact in protecting against the effects of Alzheimer's disease. The finding could lead to a new class of drugs that fight the disease.
Much of the historical research into …
-
Huntington's Disease Treatment Market Size to Worth USD 1,217.10 Million by 2032
27 Feb 2024 16:10 GMT
Ottawa, Feb. 27, 2024 (GLOBE NEWSWIRE) -- The global huntington's disease treatment market size accounted for USD 638.15 million in 2024 and is anticipated to reach around USD 890.18 million by 2029, expanding at a CAGR of 7.8% from 2023 to 2032.
…
-
Research team identifies new treatment target for Alzheimer's disease
26 Mar 2024 16:10 GMT
World Alzheimer's disease
Alzheimer's disease is the leading cause of dementia and disability in old age. As the number of people diagnosed with Alzheimer's disease is on the increase, new treatments are urgently needed to improve the quality …
-
FDA Gives Guidance on Developing Treatments for Early Alzheimer’s
15 Mar 2024 20:15 GMT
The draft guidance document provides support to sponsors with drugs in clinical development that treat the states of sporadic Alzheimer’s disease.
FDA issued a draft guidance on March 12, 2024 regarding the development of treatments for early Alzheimer’s …
-
Why some RNA drugs work better than others
07 Mar 2024 06:17 GMT
COLD SPRING HARBOR, N.Y., March 6, 2024 /PRNewswire/ -- Spinal muscular atrophy, or SMA, is the leading genetic cause of infant death. Less than a decade ago, Cold Spring Harbor Laboratory (CSHL) Professor Adrian Krainer showed this brutal disease …